印度尼西亚人体免疫缺陷病毒1型逆转录酶基因的主要耐药性突变:系统性审查
Nurjannah1,2, Sri Jayanti3, Francisca Srioetami Tanoerahardjo1
1Postgraduate School, Hasanuddin University, Makassar, 90245, Indonesia.
Current HIV/AIDS reports
|January 20, 2024
概括
在印度尼西亚,HIV-1抗药性突变正在增加,特别是在逆转录酶基因中. 监测这些突变对于患者有效的抗逆转录病毒疗法 (ART) 至关重要.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 印度尼西亚的HIV-1感染率和耐药性正在上升.
- 聚基因的突变有助于HIV-1抗逆转录病毒疗法 (ART) 的耐药性.
研究的目的:
- 审查印尼HIV-1病例中聚基因逆转录酶 (RT) 中的主要药物耐药性突变 (DRM).
主要方法:
- 2015-2020年间发表的11篇文章的系统审查,报告了印尼HIV-1受试者的DRM.
- 对DRM流行,特定突变 (M184I/V,K103N),HIV-1亚型 (CRF01_AE) 和区域差异的分析.
主要成果:
- 在RT基因中主要DRM的患病率在3.4%至34%之间.
- CRF01_AE是主要的亚型. 主要的DRM在ART经验 (22.1%) 的人群中高于在ART先验 (4.4%) 个体.
- M184I/V (10.5%) 和K103N (6.4%) 分别是最常见的NRTI和NRTI突变. 北苏拉威西的DRM患病率最高 (21.1%).
结论:
- 由于HIV-1DRM的区域差异很大,因此需要持续监测印度尼西亚的ART有效性.
- 进一步的研究是必不可少的,以了解和打击印尼HIV-1患者的DRMs的出现.
相关概念视频
Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Retrovirus Life Cycles
46.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


